Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Sheridan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Environmental Quality|September 10, 2005
Surface runoff water quality in a managed three zone riparian bufferRichard Lowrance, Joseph M Sheridan
Journal of Chemical Information and Modeling|April 8, 2021
AUTOSTERE: Systematic Search for Scaffold Replacement Opportunities within Structural DatabasesJonathan R Heal, Joseph M Sheridan, Manisha Kulkarni, et al.
Organic & Biomolecular Chemistry|December 16, 2010
Synthesis of novel PPARα/γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program PROTOBUILDYushma Bhurruth-Alcor, Therese Røst, Michael R Jorgensen, et al.
Science (New York, N.Y.)|September 20, 2008
An inhibitor of FtsZ with potent and selective anti-staphylococcal activityDavid J Haydon, Neil R Stokes, Rebecca Ure, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Environmental Quality|September 10, 2005
Surface runoff water quality in a managed three zone riparian bufferRichard Lowrance, Joseph M Sheridan
Journal of Chemical Information and Modeling|April 8, 2021
AUTOSTERE: Systematic Search for Scaffold Replacement Opportunities within Structural DatabasesJonathan R Heal, Joseph M Sheridan, Manisha Kulkarni, et al.
Organic & Biomolecular Chemistry|December 16, 2010
Synthesis of novel PPARα/γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program PROTOBUILDYushma Bhurruth-Alcor, Therese Røst, Michael R Jorgensen, et al.
Science (New York, N.Y.)|September 20, 2008
An inhibitor of FtsZ with potent and selective anti-staphylococcal activityDavid J Haydon, Neil R Stokes, Rebecca Ure, et al.
Pageof 1